MAPT and Alzheimer disease: Furthermore, we show that palmitoyl-L-carnitine contributes to tau phosphorylation along with mitochondrial dysfunction, establishing a direct link between altered acylcarnitine metabolism and a mechanistic pathway involved in AD pathology.